Skip to main content

UBS Group AG

Position in NDRA — ENDRA Life Sciences Inc.

CIK 1610520 ZURICH, V8

Position in NDRA

as of Mar 31, 2026 · filed May 5, 2026
Position Value
$706
+$652 QoQ
Shares Held
152
+1166.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NDRA Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

UBS Group AG holds $3,683,548,652 across 46 Diagnostics & Research names. NDRA ranks #43 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NDRA

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $706 152
2025-12-31 $54 12
2025-09-30 $570 106
2025-06-30 $16,479 4,695
2024-12-31 $594 95
2024-06-30 $5,378 55,453
2024-03-31 $81 140
2022-12-31 $8,750 2,150
2022-06-30 $9,350 40,133
2022-03-31 $10,997 28,200
2021-12-31 $19,514 28,200
2021-09-30 $48,799 28,208
2021-06-30 $64,961 29,799
2021-03-31 $79,332 30,513
2020-12-31 $4,577 6,104
2020-09-30 $6,746 9,217
2020-06-30 $1,242 1,292
2020-03-31 $2,125 2,944